Zhang Chengkai, Ma Shunchang, Xiao Dan, Zhang Luwen, Gui Songbai, Liu Pinan, Geng Jingyao, Yang Huizhen, Zhao Xuyang, Zhang Chuanbao, Guan Xiudong, Zhang Dainan, Zhang Liwei, Li Deling, Jia Wang
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Department of neurotomy, Beijing Neurosurgical Institute, Beijing China.
Int J Surg. 2025 Jun 24. doi: 10.1097/JS9.0000000000002889.
The comparative efficacy of endoscopic versus microscopic transsphenoidal surgery for patients with pituitary adenoma (PA) remains controversial. Previous retrospective studies have often been limited by inconsistencies in baseline characteristics of patients, which may affect the validity of the comparisons. This study aimed to evaluate the trend in the proportion of transsphenoidal endoscopic and microscopic surgeries in China and compare outcomes in comparable patients.
The National Brain Tumor Registry of China (NBTRC) database was queried to extract PA patients (2011-2021) for trend analysis. Stratified sampling was performed, and a 1:1 propensity score matching (PSM) was used to balance the patients' baseline characteristics. Postoperative outcomes, complications, and prognosis were compared.
Among the nationwide 17 012 PA patients, there was a gradual increase in the proportion of endoscopic surgeries (annual percent change, 11.89%). Among the 1863 stratified patients, those who underwent endoscopic surgery had a higher preoperative recurrence rate and higher Knosp and Hardy grades (P < 0.05). Endoscopic surgery showed a similar gross total resection (GTR) rate to microscopy (55.6% vs. 54.9%, P = 0.886) in the real-world cohort and a higher GTR rate (59.5% vs. 54.3%, P = 0.037) in the PSM cohort. After PSM, there was no significant difference in cerebrospinal fluid leak and secondary surgery (P > 0.05); endoscopic surgery showed more bleeding, longer surgical time, shorter hospital stay, and higher costs (all P < 0.001) compared to microscopic surgery. The risk of postoperative progression was similar between endoscopic and microscopic surgeries for comparable PA patients (P = 0.45).
Endoscopic transsphenoidal surgery is increasingly adopted in China, demonstrating a higher GTR rate than microscopic transsphenoidal surgery in PA patients with similar characteristics, without increasing severe complication rates. The risk of postoperative progression was similar between the two techniques.
对于垂体腺瘤(PA)患者,内镜下经蝶窦手术与显微镜下经蝶窦手术的比较疗效仍存在争议。以往的回顾性研究常常受到患者基线特征不一致的限制,这可能会影响比较的有效性。本研究旨在评估中国经蝶窦内镜手术和显微镜手术比例的变化趋势,并比较可比患者的手术结果。
查询中国国家脑肿瘤登记数据库(NBTRC),提取2011年至2021年的PA患者进行趋势分析。进行分层抽样,并采用1:1倾向评分匹配(PSM)来平衡患者的基线特征。比较术后结果、并发症和预后。
在全国17012例PA患者中,内镜手术的比例逐渐增加(年变化率为11.89%)。在1863例分层患者中,接受内镜手术的患者术前复发率较高,Knosp和Hardy分级也较高(P<0.05)。在真实世界队列中,内镜手术的全切除率与显微镜手术相似(55.6%对54.9%,P=0.886),在PSM队列中,内镜手术的全切除率更高(59.5%对54.3%,P=0.037)。PSM后,脑脊液漏和二次手术方面无显著差异(P>0.05);与显微镜手术相比,内镜手术出血更多、手术时间更长、住院时间更短且费用更高(均P<0.001)。对于可比的PA患者,内镜手术和显微镜手术术后进展的风险相似(P=0.45)。
中国越来越多地采用内镜下经蝶窦手术,在具有相似特征的PA患者中,内镜下经蝶窦手术的全切除率高于显微镜下经蝶窦手术,且未增加严重并发症发生率。两种技术术后进展的风险相似